Table 3.
Symptoms at 6 months in the included patients
| Respondersa (n = 115) |
New disability | |||
|---|---|---|---|---|
| Yes (n = 42) |
No (n = 66) |
p value | ||
| Any symptom—no. (%) | 82 (71.3) | 34 (81.0) | 46 (69.7) | 0.261 |
| Number of symptoms—no. (%) | 0.001 | |||
| 1 | 23 (20.0) | 3 (7.1) | 20 (30.3) | |
| 2 | 9 (7.8) | 3 (7.1) | 6 (9.1) | |
| ≥ 3 | 50 (43.5) | 28 (66.7) | 20 (30.3) | |
| Symptoms—no. (%) | ||||
| Shortness of breath | 40 (34.8) | 26 (61.9) | 14 (21.2) | < 0.001 |
| Loss of strength | 25 (21.7) | 19 (45.2) | 6 (9.1) | < 0.001 |
| Fatigue | 22 (19.1) | 11 (26.2) | 10 (15.2) | 0.213 |
| Persistent cough | 16 (13.9) | 10 (23.8) | 6 (9.1) | 0.051 |
| Loss of taste | 14 (12.2) | 9 (21.4) | 5 (7.6) | 0.044 |
| Loss of smell | 14 (12.2) | 9 (21.4) | 4 (6.1) | 0.030 |
| Headache | 12 (10.4) | 7 (16.7) | 3 (4.5) | 0.045 |
| Persistent chest pain | 8 (7.0) | 5 (11.9) | 2 (3.0) | 0.107 |
| Palpitations | 8 (7.0) | 4 (9.5) | 4 (6.1) | 0.709 |
| Myalgia/arthralgia | 8 (7.0) | 3 (7.1) | 5 (7.6) | 0.999 |
| Loss of sensation | 7 (6.1) | 4 (9.5) | 3 (4.5) | 0.427 |
| Hair loss | 6 (5.2) | 3 (7.1) | 3 (4.5) | 0.676 |
| Weight loss | 6 (5.2) | 3 (7.1) | 3 (4.5) | 0.676 |
| Anxiety | 5 (4.3) | 3 (7.1) | 2 (3.0) | 0.375 |
| Other | 28 (24.3) | 15 (35.7) | 12 (18.2) | 0.067 |
Data are no (%). Percentages may not total 100 because of rounding
aThe follow-up cohort comprises patients who were contacted successfully at 6 months. However, data may be missing for some outcomes depending on the willingness of the patient to answer all questions